Co-Founder & CEO
Dr Andrew Hodgson
Combines physics and stem-cell research with leadership of StemBond’s strategy, fundraising and operations.
THE PEOPLE BEHIND STEMBOND
Deep science. Shared ambition.
Bringing together mechanobiology, materials science and the experience to build a life-science business.
WHY WE EXIST
Give researchers more control over the conditions that matter.
SENCE™ brings stiffness, ECM choice and attachment into ready-to-use hydrogel culture surfaces. We turn work in cell mechanics and materials into tools researchers can use in their own biological workflows.
SCIENTIFIC ORIGINS. PRACTICAL LEADERSHIP.
Our founders.
Co-Founder & Scientific Advisor
Prof. Kevin Chalut
Co-inventor of the core technology, bringing expertise in stem-cell biology and the physics of the cellular environment.
EXPERIENCE FOR THE NEXT STAGE
Our board and advisors.
Board Chair & Advisor
Dr Robert Preti
Co-founder of Progenitor Cell Therapy, with experience in cell-therapy manufacturing, commercial growth and governance.
Board Member & Advisor
Dr Miguel Forte
Contributes biotechnology, cell-therapy and venture-investment experience, alongside clinical and regulatory perspectives.
Investor Director
Dr Jason Mellad
An early-stage life-science investor with experience in oncology, innovation and building biotechnology companies.
Investor Director
Dr Amanda Wooding
Brings university venture-building experience and a research background spanning molecular endocrinology, academia and industry.
FINANCIAL LEADERSHIP
Ready for the next stage.
Fractional Chief Financial Officer
Matt Cobbett
Matt supports StemBond’s financial planning, cash control and financing readiness.
START WITH YOUR QUESTION
The next discovery starts with a conversation.
Researcher, collaborator or investor — tell us what you’re working towards.